Filter by Industry
Filter by Topic
Expiration of enhanced ACA subsidies: What it means for providers—and how to respond
Learn how the expiration of enhanced ACA subsidies affects provider volume, payer mix, and revenue, and how data-driven forecasting can help providers…
4 overlooked growth opportunities in cardiovascular care
This American Heart Month, explore how MedTech can identify untreated cardiovascular patients to improve patient outcomes.
Phase-out of the CMS IPO list: What it means for site-of-care shifts, volumes, and revenue mix
Learn how the CMS IPO List phase-out will shift procedures to ASCs and outpatient settings—and what it means for volume, revenue mix, and strategy.
What the CDC’s updated vaccine schedule means for providers, insurers, and drugmakers
Explore how evolving CDC and ACIP vaccine recommendations are reshaping vaccination volume, claims patterns, and demand forecasting.
4 trends pharmacy leaders should know about in 2026
Explore the top pharmacy trends shaping 2026 — from GLP-1s and rising drug costs to pricing transparency, supply chain shifts, and direct-to-consumer…
Top specialty pharmacy therapy areas
Discover the top specialty pharmacy therapy areas and how prescribing trends are shaping life sciences and healthcare strategy.
Emerging biopharma launch strategies for commercial success
Explore emerging biopharma launch strategies, from targeting and market access to data-driven commercialization for emerging biopharma companies.
Discover new opportunities for your products with healthcare market data
Learn how healthcare market data helps sales and marketing teams identify new product opportunities and target high-value accounts.
What are some of the most common rare diseases?
Explore the most common rare diseases in the U.S., based on real-world claims data, and see how prevalence varies by geography.
The specialty pharmacy & IDN connection
Explore how specialty pharmacies connect to IDNs and why these relationships matter for life sciences and healthcare strategy.